Peng S - Search Results

1

A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.

Liu Y, He Y, Yang F, Cong X, Wang J, Peng S, Gao D, Wang W, Lan L, Ying X, Liu M, Chen Y, Yi Z. Liu Y, et al. Among authors: peng s. Sci China Life Sci. 2017 Feb;60(2):202-214. doi: 10.1007/s11427-016-0369-6. Epub 2017 Feb 13. Sci China Life Sci. 2017. PMID: 28194552

2

Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.

Gao C, Dai FJ, Cui HW, Peng SH, He Y, Wang X, Yi ZF, Qiu WW. Gao C, et al. Chem Biol Drug Des. 2014 Aug;84(2):223-33. doi: 10.1111/cbdd.12308. Epub 2014 Apr 30. Chem Biol Drug Des. 2014. PMID: 24612785

3

Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.

Hu M, Peng S, He Y, Qin M, Cong X, Xing Y, Liu M, Yi Z. Hu M, et al. Among authors: peng s. Oncotarget. 2015 Jun 20;6(17):15348-61. doi: 10.18632/oncotarget.3610. Oncotarget. 2015. PMID: 25915156 Free PMC article.

4

LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity.

Qin M, Peng S, Liu N, Hu M, He Y, Li G, Chen H, He Y, Chen A, Wang X, Liu M, Chen Y, Yi Z. Qin M, et al. Among authors: peng s. J Pharmacol Exp Ther. 2015 Dec;355(3):473-83. doi: 10.1124/jpet.115.225912. Epub 2015 Sep 16. J Pharmacol Exp Ther. 2015. PMID: 26377911

5

A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.

Yang F, Peng S, Li Y, Su L, Peng Y, Wu J, Chen H, Liu M, Yi Z, Chen Y. Yang F, et al. Among authors: peng s, peng y. Org Biomol Chem. 2016 Feb 7;14(5):1727-35. doi: 10.1039/c5ob02250a. Org Biomol Chem. 2016. PMID: 26732459

6

Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.

Cui HW, Peng S, Gu XZ, Chen H, He Y, Gao W, Lv F, Wang JH, Wang Y, Xie J, Liu MY, Yi Z, Qiu WW. Cui HW, et al. Among authors: peng s. Eur J Med Chem. 2016 Mar 23;111:126-37. doi: 10.1016/j.ejmech.2016.01.058. Epub 2016 Feb 1. Eur J Med Chem. 2016. PMID: 26866967

7

Synthesis of novel diterpenoid analogs with in-vivo antitumor activity.

Wang YY, He Y, Yang LF, Peng SH, He XL, Wang JH, Lv F, Hao Y, Liu MY, Yi Z, Qiu WW. Wang YY, et al. Eur J Med Chem. 2016 Sep 14;120:13-25. doi: 10.1016/j.ejmech.2016.04.071. Epub 2016 May 2. Eur J Med Chem. 2016. PMID: 27187855

8

Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.

He Y, Peng S, Wang J, Chen H, Cong X, Chen A, Hu M, Qin M, Wu H, Gao S, Wang L, Wang X, Yi Z, Liu M. He Y, et al. Among authors: peng s. Nat Commun. 2016 Dec 13;7:13122. doi: 10.1038/ncomms13122. Nat Commun. 2016. PMID: 27959342 Free PMC article.

9

Ailanthone: a new potential drug for castration-resistant prostate cancer.

Peng S, Yi Z, Liu M. Peng S, et al. Chin J Cancer. 2017 Mar 3;36(1):25. doi: 10.1186/s40880-017-0194-7. Chin J Cancer. 2017. PMID: 28257652 Free PMC article. No abstract available.

10

A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.

Wang J, Xing Y, Wang Y, He Y, Wang L, Peng S, Yang L, Xie J, Li X, Qiu W, Yi Z, Liu M. Wang J, et al. Among authors: peng s. J Exp Clin Cancer Res. 2019 Oct 22;38(1):422. doi: 10.1186/s13046-019-1392-8. J Exp Clin Cancer Res. 2019. PMID: 31640758 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,993 results

Search Page

Filters